Physician profile
Alyson N Fox
NPI 1114136967
$9,753.33
in general payments reported to CMS, 2019-2025
22 companies · $5,575 in 2025
The $5,575 reported for 2025 was more than what a typical Transplant Hepatology provider received nationally (typical 2025 total: $508).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2021: $1,020 · 2022: $1,883 · 2023: $219 · 2024: $669 · 2025: $5,575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,840 · Food and Beverage: $2,479 · Travel and Lodging: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,840.00 |
| Food and Beverage | $2,479.11 |
| Travel and Lodging | $144.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $4,158.41 | 2024-2025 | Iqirvo |
| Takeda Pharmaceuticals U.S.A., INC. | $2,595.00 | 2021-2022 | |
| Madrigal Pharmaceuticals | $523.48 | 2025 | Rezdiffra |
| Gilead Sciences, INC. | $373.64 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $278.24 | 2022-2025 | Givlaari, Oxlumo |
| Paragonix Technologies, INC. | $238.60 | 2025 | Liverguard |
| Trisalus Life Sciences, INC. | $229.11 | 2024 | Trinav Infusion System |
| Fujifilm Healthcare Americas Corporation | $207.70 | 2024-2025 | Utaswako Afp-L3 |
| Mallinckrodt Hospital Products INC. | $190.31 | 2023-2025 | Terlivaz |
| Orphalan INC | $175.58 | 2024-2025 | Cuvrior |
| Dova Pharmaceuticals | $156.36 | 2019 | |
| Organox LTD | $134.52 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $119.05 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $106.70 | 2022-2025 | Xifaxan |
| Intuitive Surgical, INC. | $60.35 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $51.18 | 2024-2025 | |
| Intra-Sana Laboratories | $37.18 | 2025 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Amgen INC. | $31.51 | 2025 | Uplizna |
| Ethicon US, LLC | $23.87 | 2024 | Certus 140 |
| Pentax of America, INC. | $22.88 | 2025 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Boston Scientific Corporation | $21.50 | 2024 | Spyglass Discover |
| Mirum Pharmaceuticals, INC. | $18.16 | 2024 | Livmarli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyson Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.